Toxicity profile of patients treated with proton and carbon‐ion therapy for primary nasopharyngeal carcinoma: A systematic review and meta‐analysis
- 22 January 2023
- journal article
- review article
- Published by Wiley in Asia-Pacific Journal of Clinical Oncology
- Vol. 20 (2) , 240-250
Abstract
Background: Proton and carbon‐ion therapy may spare normal tissues in regions with many critical structures surrounding the target volume. As toxicity outcome data are emerging, we aimed to synthesize the published data for the toxicity outcomes of proton or carbon‐ion therapy (together known as particle beam therapy [PBT]) for primary nasopharyngeal carcinoma (NPC).Materials and methods: We searched PubMed and Scopus electronic databases to identify original studies reporting toxicity outcomes following PBT of primary NPC. Quality assessment was performed using NIH's Quality Assessment Tool. Reports were extracted for information on demographics, main results, and clinical and dose factors correlates. Meta‐analysis was performed using the random‐effects model.Results: Twelve studies were selected (six using mixed particle‐photon beams, five performed comparisons to photon‐based therapy). The pooled event rates for acute grade ≥2 toxicities mucositis, dermatitis, xerostomia weight loss are 46% (95% confidence interval [95% CI]—29%–64%, I2 = 87%), 47% (95% CI—28%–67%, I2 = 87%), 16% (95% CI—9%–29%, I2 = 76%), and 36% (95% CI—27%–47%, I2 = 45%), respectively. Only one late endpoint (xerostomia grade ≥2) has sufficient data for analysis with pooled event rate of 9% (95% CI—3%–29%, I2 = 77%), lower than intensity‐modulated radiotherapy 27% (95% CI—10%–54%, I2 = 95%). For most endpoints with significant differences between the PBT and photon‐based therapies, PBT resulted in better outcomes. In two studies where dose distribution was studied, doses to the organs at risk were independent risk factors for toxicities.Conclusion: PBT may reduce the risk of acute toxicities for patients treated for primary NPC, likely due to dose reduction to critical structures. The pooled event rate for toxicities derived in this study can be a guide for patient counseling.Keywords
This publication has 43 references indexed in Scilit:
- Intensity-modulated radiation therapy versus 2D-RT or 3D-CRT for the treatment of nasopharyngeal carcinoma: A systematic review and meta-analysisOral Oncology, 2015
- Global cancer statistics, 2012CA: A Cancer Journal for Clinicians, 2015
- Racial differences in nasopharyngeal carcinoma in the United StatesCancer Epidemiology, 2013
- Trends in the survival of patients with nasopharyngeal carcinoma between 1976 and 2005 in Sihui, China: a population-based studyChinese Journal of Cancer, 2013
- Selection of patients for radiotherapy with protons aiming at reduction of side effects: The model-based approachRadiotherapy and Oncology, 2013
- A Phase II Trial of Proton Radiation Therapy With Chemotherapy for Nasopharyngeal CarcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Nasopharyngeal carcinoma in Indonesia: epidemiology, incidence,signs, and symptoms at presentationChinese Journal of Cancer, 2012
- Comparison of intensity-modulated radiotherapy, adaptive radiotherapy, proton radiotherapy, and adaptive proton radiotherapy for treatment of locally advanced head and neck cancerRadiotherapy and Oncology, 2011
- Systematic review and meta-analysis of radiotherapy in various head and neck cancers: Comparing photons, carbon-ions and protonsCancer Treatment Reviews, 2011
- Biological characteristics of carbon-ion therapyInternational Journal of Radiation Biology, 2009